The overwhelming popularity of GLP-1 drugs – what President Trump calls “the fat shot” – has insurance companies scrambling to satisfy consumer access to the treatments while at the same time reining ...
Novo Nordisk has lost ground in the weight-loss drug market to Eli Lilly and telehealth companies. The company's new CEO is being far more aggressive, which bodes well. Novo's upcoming Wegovy pill is ...
A new study hints that pregnant people who have previously taken drugs like Ozempic may face a higher risk of certain poor pregnancy outcomes. But more studies are needed to understand the finding.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback